Glutamatergic Neurotransmission As Molecular Target of New Anticonvulsants

By  

Current Topics in Medicinal Chemistry, Vol. 12, Iss. 9, 2012-05 ,pp. : 971-993

Bentham Science Publishers

Access to resources Recommend Favorite

Towards the Targeted Therapy of Melanoma

By  

Mini Reviews in Medicinal Chemistry, Vol. 6, Iss. 4, 2006-04 ,pp. : 387-393

Bentham Science Publishers

Access to resources Recommend Favorite

Editorial (Thematic Selection: #39;Glutamatergic-based Rapid Acting Antidepressants: The Link to Synaptic Plasticity#39;)

By  

Current Neuropharmacology, Vol. 15, Iss. 1, 2016-12 ,pp. : 2-2

Bentham Science Publishers

Access to resources Recommend Favorite

Interactions of antidepressants with the serotonin transporter: a contemporary molecular analysis

By Roman D.L.   Walline C.C.   Rodriguez G.J.   Barker E.L.  

European Journal of Pharmacology, Vol. 479, Iss. 1, 2003-10 ,pp. : 53-63

Elsevier

Access to resources Recommend Favorite

The Glutamatergic Aspects of Schizophrenia Molecular Pathophysiology: Role of the Postsynaptic Density, and Implications for Treatment

By  

Current Neuropharmacology, Vol. 12, Iss. 3, 2014-05 ,pp. : 219-238

Bentham Science Publishers

Access to resources Recommend Favorite